1998
DOI: 10.1016/s0960-8966(98)00004-2
|View full text |Cite
|
Sign up to set email alerts
|

Effect of vitamin B6 supplementation in McArdle's disease: a strategic case study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
19
0

Year Published

2000
2000
2015
2015

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(19 citation statements)
references
References 6 publications
0
19
0
Order By: Relevance
“…Therefore, supplementation of vitamin B6 has been hypothesized to activate the residual phosphorylase activity. The effect of vitamin B6 (oral 50 mg/day supplementation for two years) in a McArdle disease patient was reported by Phoenix et al in 1998 in a patient-blind study (10). But thereafter there have been few reports suggesting the efficacy of vitamin B6.…”
Section: Discussionmentioning
confidence: 90%
“…Therefore, supplementation of vitamin B6 has been hypothesized to activate the residual phosphorylase activity. The effect of vitamin B6 (oral 50 mg/day supplementation for two years) in a McArdle disease patient was reported by Phoenix et al in 1998 in a patient-blind study (10). But thereafter there have been few reports suggesting the efficacy of vitamin B6.…”
Section: Discussionmentioning
confidence: 90%
“…So Vit B 6 is considered to be associated with energy metabolism. It has been reported that Vit B 6 plays an active part in promoting amino acid metabolism and recovery of peripheral nerve 23) . In other paper, administration of Vit B6 can enhance the utilization of selenium, increase glutathione peroxidase (GSH-Px) activity in erythrocyte, skeletal muscle, myocardium and testis 24) , and decrease lipid peroxides levels 25) .…”
Section: Discussionmentioning
confidence: 99%
“…Vitamin B 6 has also been used because overall body stores of pirydoxal phosphate are depleted in McArdle's disease patients. A beneficial effect has been documented in one patient but this requires confirmation [50]. A placebocontrolled, crossover trial of creatine monohydrate in nine patients showed improvement in symptoms and increases in their capacity for ischemic, isometric forearm exercise [51].…”
Section: Managementmentioning
confidence: 97%